Embryonic neural stem/progenitor cells as model to characterize dystrophin and dystrophin-associated proteins expression during neuronal or astrocytic differentiation

Neural stem/progenitor cells (NSPC) are multipotent cells that renew themselves and could differentiate into neurons and macro glia (astrocytes and oligodendrocytes) of the nervous system during embryonic development. Duchenne muscular dystrophy is a severe type of muscular dystrophy caused by mutations in the dmd gene, and one-third of patients cursed with neuro-cognitive impairments. In this data article, we take advantage of the differentiation capacity of NSPC as a model to increase our knowledge in the neuronal and/or astrocytic differentiation and to evaluate the expression of dystrophins and dystrophin-associated proteins. We showed the characterization of undifferentiated and neuron and/or astrocyte differentiated NSPC. In addition, we evaluated the expression and subcellular localization of dystrophins and β-dystroglycan in undifferentiated NSPC and differentiated to neurons and astrocytes.• Primary culture of NSPC was characterized by the expression of multipotent markers nestin and Sox2.• Neuronal or astrocytic differentiation of NSPC was performed by basic fibroblast growth factor (FGF2) withdrawal, histamine or ciliary neurotrophic factor (CNTF) treatment, and expression of βIII-tubulin or glial fibrillary acidic protein (GFAP) as differentiation markers for neurons or astrocytes was evaluated.• This study will contribute to the understanding of dystrophins and dystrophin-associated proteins expression and function during neuronal or astrocytic differentiation of NSPC


Specifications table
All data are presented in this article.

Background
Neural stem/progenitor cells (NSPC) can be isolated from several brain regions and maintained in an undifferentiated state in vitro with mitogenic factors, such as basic fibroblast growth factor (FGF2). The FGF2 deprivation induces the differentiation of NSPC into neurons, astrocytes and oligodendrocytes [1] , while the addition of histamine [2] or ciliary neurotrophic factor (CNTF) [3] promotes neuronal or glial differentiation, respectively. Here, we reported the isolation, culture and characterization of embryonic NSPC as a model to explore the expression and function of dystrophins and dystrophin-associated proteins (DAPs) during the neuronal or astrocytic differentiation. NSPC were differentiated with FGF2 deprivation and histamine or CNTF treatment. The expression of nestin as a multipotent marker, βIII-tubulin as a neuronal marker and GFAP as an astrocytic marker, was evaluated ( Fig. 1 ). NSPC were also characterized by immunostaining for nestin, βIII-tubulin, dystrophins and β-dystroglycan ( Fig. 2 ). Additionally, expression of dystrophins and dystrophinassociated proteins complex (DAPC) in proliferating and differentiating NSPC was characterized [4] .

Animals
Adult female Wistar rats at 7 to 9 weeks-old and at least 200 g weight in oestrus were mated for 24 h with male Wistar rats at UPEAL-(Unit for Production and Experimentation of Laboratory Animals) Cinvestav. Animals were cared and handled following the guidelines for the use of laboratory animals provided by the CICUAL-(Internal Committee for the Care and Use of Laboratory Animals) Cinvestav and Mexican Official Norm (NOM-062-ZOO-1999).
Cells were seeded at 6 × 10 5 in 6-cm diameter culture dishes previously treated with 15 μg/ml poly-L-ornithine (Sigma), and 1 μg/ml human fibronectin (Invitrogen) in N2 medium or Neurocult medium (Stem cell technologies) containing 10 ng/ml FGF2 (Peprotech). FGF2 was added daily, and the medium was changed every other day. The initial plating was considered passage 0 (P0), and when cells reached 80% confluence, they were detached and re-plated to P1 and, subsequently, to P2 to obtain a homogeneous cell population. P2 cells were maintained for 4 days in the control (N2 medium + 10 ng/ml FGF2) and experimental conditions (N2 medium + 10 ng/ml FGF2 with 100 μM histamine or 10 ng/ml CNTF). Then, differentiation was induced by FGF2 withdrawal, in the presence of 200 μM ascorbic acid as an antioxidant to avoid cell death added every three days, and maintaining histamine or CNTF treatment, which was added daily.

RNA extraction and semi-quantitative RT-PCR
Total RNA was extracted using TRIzol (Invitrogen). Six to eight micrograms of RNA, treated with RNase-free DNase1, was retro-transcribed into cDNA using random hexamers (Invitrogen) and M-MLV reverse transcriptase (Promega), according to the manufacturer's instructions. cDNAs were amplified by PCR in a 25 μl reaction volume containing 0.5 μg cDNA and specific primers ( Table 1 ). The PCR conditions comprised an initial denaturation at 94 °C for 5 min, followed by 18-30 cycles at 94 °C for

Immunofluorescence staining
NSPC were grown on coverslips pre-coated with poly-L-ornithine and fibronectin. Cells were fixed with 4% paraformaldehyde (PFA) for 2 min followed by 2% PFA for an additional 20 min, were washed three times with PBS and were blocked for 1 h with 10% normal goat serum (NGS) in PBS. Cells were incubated overnight at 4 °C with the primary antibodies diluted in PBS containing 10% NGS:

Statistical analysis
Statistical analyses were carried out with the GraphPad Prism 5 software. Data from three independent experiments were analyzed using unpaired Student t-tests. Statistical significance was considered when the P value was < 0.05.

Expression of nestin, βIII-tubulin and GFAP during NSPC differentiation
Cells from the developing rat telencephalic vesicles were dissociated and kept in culture with FGF2. During the first passage, the cortical cerebral cell cultures contained a mixture of neural stem cells with progenitors and immature neurons, and in the subsequent passages, the proportion of NSPC increased. The undifferentiated state of NSPC can be verified with molecular markers, such as the transcriptional regulator Sox2, the intermediate filament protein nestin and/or surface antigens, such as Lex [9][10][11][12] . P2 NSPC were maintained in an undifferentiated state by adding FGF2 and differentiation was induced by FGF2 withdrawal and histamine or CNTF treatment. To determine the nature of isolated NSPC, we analyzed the expression of multipotent (nestin and Sox2) and differentiation markers, with βIII-tubulin as a neuronal marker and GFAP as an astrocytic marker. As expected, the level of nestin mRNA was significantly down-regulated, whereas the levels of βIIItubulin and GFAP mRNA were up-regulated upon FGF2 withdrawal and histamine or CNTF treatment ( Fig. 1 A), with similar results obtained at the protein level ( Fig. 1 B). Proliferating NSPC at P2 were also immuno-positive for both nestin and Sox2 [4] and were immuno-negative for βIII-tubulin and GFAP (data not shown), while differentiated cells were positive for βIII-tubulin, MAP2 and GFAP [4] .

Subcellular localization of dystrophins and β-dystroglycan in undifferentiated NSPC
As part of the characterization of NSPC, subcellular localization of dystrophins and β-dystroglycan as well as nestin and βIII-tubulin was analyzed on P0 and P1 cells. At P0, the level of nestin-immunopositive cells reached 87% ± 10.6, while βIII-tubulin reached 17.3% ± 8.2 ( Fig. 2 D and J). As expected, no GFAP-positive cells were observed (data not shown). Interestingly, most of the nestin-positive cells were also positive for dystrophins (92.2% ± 11. 2), which were localized in the cytoplasm and cellular periphery, and in some cells, a slight staining was also observed in the nucleus ( Fig. 2 B and C). In addition, most of the βIII-tubulin-positive cells presented 99% ± 1.6 immunopositivity for dystrophins with two cell populations, one of which had predominant cytoplasm and cell periphery staining, and the other, which had cytoplasmic, cell periphery and nuclear localization ( Fig. 2 E and F). However, we were unable to determine whether such a differential subcellular distribution was related to the differences in specific dystrophin expression because the antibody used recognized exon 78, a common region for most of the dystrophin gene products. Regarding β-dystroglycan immunostaining, we observed that almost all the nestin-positive cells co-expressed β-dystroglycan (93.6% ± 2.5) and localized prominently in the cytoplasm and cellular periphery, and some cells showed clear nuclear staining ( Fig. 2 G and I). Similar to the dystrophin staining, most of the βIII-tubulin-positive cells co-expressed β-dystroglycan (98.9% ± 1.4), with two cell populations being observed: the first demonstrated β-dystroglycan localization principally in the cytoplasm and cell periphery, and the second having β-dystroglycan localization in the cytoplasm, cell periphery and nucleus ( At P1, the level of nestin-positive cells reached 90% ± 6.4 and that of βIII-tubulin reached 12.5% ± 3.3, while no GFAP-positive cells were found (data not shown). The subcellular localization of dystrophins and β-dystroglycan was basically the same as that at P0, and nestin-positive cells co-expressed dystrophins (99% ± 1.54) and β-dystroglycan (94.5% ± 8.7). βIII-tubulin-positive cells co-expressed dystrophins (99.6% ± 0.3) and β-dystroglycan (95.6% ± 7.6). Two populations of βIII-tubulin-positive cells were recognized: the first demonstrated subcellular localization of dystrophins and β-dystroglycan in the cytoplasm and cellular periphery, and the second demonstrated cytoplasmic, cellular periphery and nuclear staining (data not shown). In addition, subcellular localization of dystrophins and β-dystroglycan was evaluated at P2 and in differentiated NSPC.
Interestingly, localization of dystrophins using Dys2 antibody was observed in the cytoplasm, cellular periphery, and in the nucleus as it was detected with H4 antibody [4] .

Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.